Philips Second Quarter Results 2014 - Healthcare Sector
 Philips reports Q2 sales of EUR 5.3 billion and EBITA of EUR 415 million. Healthcare comparable sales showed a 4% decline year-on-year. The EBITA margin, excluding restructuring and acquisition-related charges, declined to 10.5%, a decrease of 3.8 percentage points year-on-year. Equipment order Q2 2014 Quarterly report and Semi-annual report intake in Europe and growth geographies showed a high-single-digit increase, while North America posted a double-digit decline.
Philips reports Q2 sales of EUR 5.3 billion and EBITA of EUR 415 million. Healthcare comparable sales showed a 4% decline year-on-year. The EBITA margin, excluding restructuring and acquisition-related charges, declined to 10.5%, a decrease of 3.8 percentage points year-on-year. Equipment order Q2 2014 Quarterly report and Semi-annual report intake in Europe and growth geographies showed a high-single-digit increase, while North America posted a double-digit decline.				 Agfa HealthCare has won a highly competitive bid for a vendor-neutral archive (VNA) and an enterprise imaging workflow solution, for two major academic hospitals in the Netherlands: the Vrije Universiteit Medisch Centrum (VUmc) and the Academisch Medisch Centrum (AMC). This agreement is the result of a tender for the "EVA" project, a collaboration between the two hospitals for implementing a new electronic health record (EHR).
Agfa HealthCare has won a highly competitive bid for a vendor-neutral archive (VNA) and an enterprise imaging workflow solution, for two major academic hospitals in the Netherlands: the Vrije Universiteit Medisch Centrum (VUmc) and the Academisch Medisch Centrum (AMC). This agreement is the result of a tender for the "EVA" project, a collaboration between the two hospitals for implementing a new electronic health record (EHR).				 Apple® and IBM (NYSE: IBM) have announced an exclusive partnership that teams the market-leading strengths of each company to transform enterprise mobility through a new class of business apps - bringing IBM's big data and analytics capabilities to iPhone® and iPad®. The landmark partnership aims to redefine the way work will get done, address key industry mobility challenges and spark true mobile-led business change - grounded in four core capabilities:
Apple® and IBM (NYSE: IBM) have announced an exclusive partnership that teams the market-leading strengths of each company to transform enterprise mobility through a new class of business apps - bringing IBM's big data and analytics capabilities to iPhone® and iPad®. The landmark partnership aims to redefine the way work will get done, address key industry mobility challenges and spark true mobile-led business change - grounded in four core capabilities:				 Tunstall Healthcare, the leading provider of technology enabled care services, has launched a new advisory service to help commissioners and providers navigate a clear path towards the mainstream implementation of technology, in order to realise the many benefits of telehealthcare.
Tunstall Healthcare, the leading provider of technology enabled care services, has launched a new advisory service to help commissioners and providers navigate a clear path towards the mainstream implementation of technology, in order to realise the many benefits of telehealthcare.				 Recent research from Imperial College London suggests that almost six million patients a year are turning to A&E because they cannot get an appointment with their GP. At the same time, iPLATO Research published a report concluded that 180,000 people used the iPLATO system to cancel their appointment during the 2013/14 financial year.
Recent research from Imperial College London suggests that almost six million patients a year are turning to A&E because they cannot get an appointment with their GP. At the same time, iPLATO Research published a report concluded that 180,000 people used the iPLATO system to cancel their appointment during the 2013/14 financial year. 				 Allscripts (NASDAQ: MDRX) announced the acquisition of privately-held Oasis Medical Solutions Limited, a London-based Patient Administration System (PAS) and health informatics solution provider. The OasisTM PAS system, developed over 18 years in partnership with numerous NHS trusts, provides flexible, efficient and scalable administrative workflow across all venues of care.
Allscripts (NASDAQ: MDRX) announced the acquisition of privately-held Oasis Medical Solutions Limited, a London-based Patient Administration System (PAS) and health informatics solution provider. The OasisTM PAS system, developed over 18 years in partnership with numerous NHS trusts, provides flexible, efficient and scalable administrative workflow across all venues of care.